Nova Eye Medical LtdASX: EYE

Bell Potter Healthcare Conference Presentation

· Issued by Nova Eye Medical Ltd via ASX

Filed with ASX · · 19 pages · English

Summary by 6ix AI

Nova Eye Medical Ltd presented at the Bell Potter Healthcare Conference, discussing its growth and financial performance for the first quarter of the fiscal year. The company reported a significant increase in sales compared to the previous corresponding period, highlighting strong revenue growth in the interventional glaucoma market. Cash flow from operations turned positive, indicating improved financial health and operational efficiency. The presentation confirmed guidance for the fiscal year, projecting continued growth in sales and positive EBITDA.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Nova Eye Medical Limited (ASX: EYE) Bell Potter Healthcare Conference 2026 Tuesday 17 November 2026 | Q1 FY27 | Tom Spurling, Managing Director Disclaimer This presentation has been prepared by Nova Eye Medical Limited (ASX: EYE). While the information in this presentation has been prepared in good...

Nova Eye Medical Ltd on 6ix

In the deck

Story so far

Earlier from Nova Eye Medical

Later from Nova Eye Medical

All Nova Eye Medical news releases